Learning Objectives:
1. To understand the need for timely referral, assessment, pre-transplant optimization, and listing for potential lung transplant candidates.
2. To identify how a history of pre-transplant malignancy (both hematologic and solid organ) and cancer treatment impacts lung transplant candidacy and timing of transplant evaluation and listing.
3. To understand pre-lung transplant management of extrapulmonary manifestations of connective tissue diseases in the transplant candidate.
Session date:
09/27/2021 - 4:00pm to 5:00pm CDT
Location:
Zoom
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Renea Jablonski, MD; Kevin Tsui, MD